Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Methyl aminolaevulinate photodynamic therapy (MAL-PDT) is an effective treatment for Bowen's
disease (BD) of the lower extremities. Er:YAG ablative fractional laser (AFL) treatment
removes the stratum corneum to increase MAL uptake and may improve efficacy. However, no
studies have directly compared the efficacy of MAL-PDT with and without Er:YAG AFL in
treating BD of the lower extremities in Asians.